Gene · 6335
Papers3,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uncovering common genetic risk factors in migraine and epilepsy through whole exome sequencing. | Epileptic Disord | 2026 | 41386636 | PubTator, text mining | PubMed |
| NRF2 activation resolves neuropathic pain via dual antioxidant and NaV1.7-Suppressive mechanisms. | Mol Ther | 2026 | 41376164 | PubTator, text mining | PubMed |
| Combination of two Na+ channel-inhibiting anticonvulsants lacosamide and phenytoin: An additive, synergistic, or antagonistic effect? | Biochem Pharmacol | 2026 | 41352563 | PubTator, text mining | PubMed |
| A nociceptor excitability test for identifying alterations of the Nav1.7 channels in humans. | Pain | 2026 | 41263818 | PubTator, text mining | PubMed |
| Discovery of O-alkylated derivative of piperine as Nav1.7 channel inhibitor for the treatment of pain. | Bioorg Med Chem Lett | 2026 | 41197882 | PubTator, text mining | PubMed |
| Genetic and Clinical Insights into Inherited Erythromelalgia: A Comprehensive Review of Cases from China and Worldwide. | J Invest Dermatol | 2026 | 41190974 | PubTator, text mining | PubMed |
| Sodium Channel Inhibitors in Clinical Development for Pain Management: A Focused Review. | CNS Drugs | 2026 | 41182481 | PubTator, text mining | PubMed |
| Pharmacology Update: Suzetrigine: A Novel NaV1.8 Sodium Channel Inhibitor for Acute Pain Management. | Am J Hosp Palliat Care | 2026 | 40601424 | PubTator, text mining | PubMed |
| An explainable artificial intelligence framework reveals mutations associated with drug resistance in Mycobacterium tuberculosis. | Biosaf Health | 2025 | 41541062 | PubTator, text mining | PubMed |
| Special Issue "Ion Channels as a Therapeutic Target: Drug Design and Pharmacological Investigation 2.0. | Int J Mol Sci | 2025 | 41516269 | PubTator, text mining | PubMed |
| Learning molecular traits of human pain disease via voltage-gated sodium channel structure renormalization. | Comput Struct Biotechnol J | 2025 | 41487283 | PubTator, text mining | PubMed |
| Recombinant Production, SpeciesSpecific Activity at the TRPA1 Channel, and Significance of the N-Terminal Residue of ProTx-I Toxin from Thrixopelma Pruriens Tarantula Venom. | Acta Naturae | 2025 | 41479563 | PubTator, text mining | PubMed |
| Mepyramine targets mutant Nav1.7 channels to relieve pain and erythema in primary erythromelalgia patients. | Front Med (Lausanne) | 2025 | 41458489 | PubTator, text mining | PubMed |
| [Genetic analysis of four children with CHARGE syndrome and a literature review]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 41451487 | PubTator, text mining | PubMed |
| Neuroinflammation-Modulating Properties Combining Glutathione, N-Acetylcysteine, and Uridine Monophosphate in a Formulation Supplement: An In Vitro Study. | Brain Sci | 2025 | 41440136 | PubTator, text mining | PubMed |
| Comprehensive Proteomic Profiling of Human Nav1.7-Interacting Proteins Reveals Conserved Regulatory Networks Involved in Nociceptive Signaling. | Neurosci Insights | 2025 | 41393971 | PubTator, text mining | PubMed |
| Venom Peptides Across Asian and American Tarantulas Utilize Dual Pharmacology to Target Activation and Fast Inactivation of Voltage-Gated Sodium Channels. | Toxins (Basel) | 2025 | 41295876 | PubTator, text mining | PubMed |
| Integrated bioinformatics screening and experimental validation: construction of a LUAD prediction model based on Treg-related genes. | PeerJ | 2025 | 41244203 | PubTator, text mining | PubMed |
| Diffusion Tensor Imaging Reveals Altered Centrality of Pain-Related Regions in SCN9A-Associated Small Fiber Neuropathy. | J Neuroimaging | 2025 | 41216932 | PubTator, text mining | PubMed |
| Integration of a 4-gene risk score model enhances prognostic accuracy in acute myeloid leukemia. | Cell Cycle | 2025 | 41163355 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6335/papers?page=6